期刊文献+

霉酚酸酯对糖尿病大鼠肾脏的保护作用及其对MIF、MCP-1表达影响的研究 被引量:4

The effect of mycophenolate mofetil on the renal protection and the expression of MCP1 and MIF in diabetic rats
下载PDF
导出
摘要 目的研究霉酚酸酯对糖尿病大鼠的保护作用,并探讨其作用机制,对MCP-1、MIF表达的影响。方法选取雄性Wistar大鼠55只,行右肾切除术后两周,随机分成模型组和正常对照组(A组),将糖尿病模型组大鼠随机分为糖尿病大鼠对照组(B组)和糖尿病大鼠治疗组(C组)。应用酶免疫分析法测定大鼠24h尿白蛋白排泄率,采用HE、PAS染色,行肾脏组织形态学分析,用Real time FQ-PCR检测MCP-1、MIF等细胞因子的mRNA表达情况。结果和B组(13.71±0.62)相比,C组大鼠尿白蛋白排泄率明显下降(4.32±0.30),差异具有统计学意义(P<0.05);C组KW/BW、MGV、FMA比B组有不同程度的下降(P<0.05);C组大鼠肾脏MCP-1、MIF的mRNA表达有所下调(P<0.05),但仍高于A组;MCP-1、MIFmRNA表达水平与UAER成正相关(r=0.703,P<0.05;r=0.657,P<0.05);MCP-1mRNA表达水平与KW/BW、MGV、FMA成正相关(r=0.651,P<0.05;r=0.639,P<0.05;r=0.771,P<0.05);MIFmRNA表达水平与KW/BW、MGV、FMA成正相关(r=0.567,P<0.05;r=0.593,P<0.05;r=0.876,P<0.05)。结论霉酚酸酯对糖尿病大鼠肾脏可起到保护作用,其机制可能与下调MCP1、MIFmRNA的表达有关。 Objective:To assess the renal protective effects and the expression of MCP1mRNA and MIF mRNA of myclate mofetil(MMF) in diabetic model rats.Methods:55 Male Wistar rats were randomized into the following groups:(A) normal control;(B) diabetic control;(C)diabetic treatment group(MMF group).24h urinary albumin excretion rate(UAER) was detetcted by Enzyme immunoassay;The renal patho-logical changes of renal tissue were observed by HE,PAS stain;Expressions of MCP-1 and TIMP-1mRNA in renal tissue were detected by Real time FQ-PCR.Results:UAER of group C(4.32±0.30)was significantly lower than that of group B(13.71±0.62)(P 0.05);KW/BW,MGV and FMA of group C were significantly lower than that of group B(P 0.05);Expressions of MCP-1 and MIFmRNA of group C were significantly lower than group B,but still higher than group A;and which were possotively correlated with 24h UAER,KW/BW,MGV and FMA(P 0.05).Conclusion:MMF has protective effect to diabetic kidney.The mechanism may be correlated with down-regulating the expression of MCP-1 and MIF.
出处 《泰山医学院学报》 CAS 2012年第12期824-827,共4页 Journal of Taishan Medical College
基金 泰安市科技局立项项目(2007-4051)
关键词 糖尿病肾病 霉酚酸酯 单核细胞趋化蛋白-1(MCP1) 巨噬细胞移动抑制因子(MIF) diabetic nephropathy mycophenolate mofetil(MMF) monocyte chemoattractant protein-1 macrophage emigration inhibitory factor
  • 相关文献

参考文献15

  • 1Mensah-Brown EPK, Obineche EN, Galadari S, et al. Streptozoto- cin-induced diabetic nephropathy in rats:The role of inflammatory cytokines[J]. Cytokine,2005,31 (3) :180K-190.
  • 2Lee SH,Lee TW,Ihm CG,et al. Genetics of diabetic nephropathy in type 2 DM : candidate gene analysis for the pathogenic role of in- flammation [ J ]. Nephrology,2005,10 : S32-$36.
  • 3Ota T,Takamura T,Ando H,et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macro- phage recruitment in a rat mode [ J ]. Diabeto|ogia,2003,46 (6) : 843 -851.
  • 4吕学爱,关广聚,孔刚.巨噬细胞移动抑制因子及巨噬细胞在糖尿病大鼠肾脏的表达及其意义[J].泰山医学院学报,2007,28(12):924-927. 被引量:4
  • 5Utimura R, Kazue C, Fujihara CK, et al. Mycophenolate mofetil prevents the dlevelopment of glomerular injury in experimental dia- betes[ J]. Kidney Int,2003, 63:209-216.
  • 6Glomsda BA, Blaheta RA, Hailer NP. Inhibition of monocyte/endo- thelial cell interactions and monocytc adhesion molecule expression by immunosuppmssant mycophenolate mofetil [ J ]. Spinal Cord, 2003,41 ( 11 ) : 610-619.
  • 7Wu Y,Dong J,Yuan L,et al. Nephrln and pedocin loss is preven- ted by myco- pheno-late mofetil in early experimental diabetic ne- phropathy[ J]. Cytokine,2008, 44 ( 1 ) :85-91.
  • 8Sassy-Prigent C, Didier Heudes, Chantal Mandet ,et al. Early glo- merttlar Macro- phage recruiment in streptozotocin-indueed diabet- ic rats[J] Diabetes. 2000,49 (3) : 466-475.
  • 9黄晓丽,吕永曼,罗建峰,易艳.霉酚酸酯对糖尿病大鼠肾脏的保护作用[J].基础医学与临床,2007,27(4):421-425. 被引量:3
  • 10Sasaki S, Nishihira J, Ishibashi T, et al . Transgene of MIF in- duces podocyte injury and progressive mesangial sclerosis in the mouse kidney [ J ]. Kidney Int, 2004,65:469-481.

二级参考文献17

  • 1Ginzler EM, Aranow C. Mycophenolate mofetil in lupus nephritis [J]. Lupus, 2005,14 ( 1 ) : 59 - 64.
  • 2Joy MS, Hogan SL, J enette JC, et al. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis [ J ]. Nephron Dial Transplant, 2005, 20(12) : 2725 -2732.
  • 3Sintchak MD, Flueming MA, Futer O, et al. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid[J]. Cell, 1996, 85:921 -930.
  • 4Allison AC, Eugui EM. Mycophenolate mofetil and its mechanism of action [ J ]. Immunophannacology, 2000, 47:85 - 118.
  • 5Hauser IA, Render L, Radeke HH, et al. Myeophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion [J]. Nephrol Dial Transplant,1999, 14:58-63.
  • 6Glomsda BA, Blaheta RA, Hailer NP. Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil[J]. Spinal Cord, 2003, 41(11): 610 -619.
  • 7Utimura R, Kazue C, Fujihara CK, et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes[J]. Kidney Int, 2003, 63:209-216.
  • 8Morii T, Fujita H, Narita T, et al. Association of monocyte chemoattractunt protein-1 with renal tubular damage in diabetic nephrepathy[J]. J Diabetes Complica, 2003,17 (1) :11-15.
  • 9Nakajima K, Tanaka Y, Nomiyama T, et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects [ J ]. Diabetes Care, 2003,26 (3) :892-898.
  • 10Sasaki S, Nishihira J, Ishibashi T, et al. Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney [J]. Kidney Int, 2004,65:469-481.

共引文献5

同被引文献56

  • 1Montserrat B Duran-Salgado,Alberto F Rubio-Guerra.Diabetic nephropathy and inflammation[J].World Journal of Diabetes,2014,5(3):393-398. 被引量:178
  • 2韦凌云,杨丕坚,李舒敏,吕以培,黄中莹,黄虹.炎症及内皮功能障碍与糖尿病肾病患者尿蛋白的相关性[J].中国老年学杂志,2014,34(9):2445-2447. 被引量:20
  • 3Ola T,Takanmra T,Ando H,et al. Preventivv effect d cerlvastafin on di- abetic nephropathy through suppression of glomerular macrophagv re- cruitment in a rat mode[J]. Diabetologia,2003,46(6) : 843 -851.
  • 4Yashpal Skanwar, Jun Wada, Lin Sun, et al. Diabetic nephropathy. mechanisms of renal disease progression [J]. Exp BiolM ed, 2008 (233): 4-11.
  • 5Xu H, Nakayama K, Ogawa S, et al. Elevated plasma concentration of IP - 10 in patients with type 2 diabetes mellitus[J]. Nippon Jinzo Gakkai Shi. 2005,47 (5) :524 -530.
  • 6J. A. Satriano, B. Banas,B. Luckow, et al. Regulation of RANTS and/CAM - 1 expresslon in murine mesaagla] ceils[J]. J Am Soc Nephrol. 1997, 8,596 -603.
  • 7Navarro JF, Mora C, Maea M, et al. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mel]itus[ J]. Am J Kidney Dis. 2003,42 ( 1 ) :53 - 61.
  • 8IL Gong,A. Rifai,E. M. Tolbert, et al. Hepatocyte growth factor amelio- rates renal interstitial inflammation in rat remnant kideny by modulating tubular expression of macrophagv chemoattmctant protein - 1 and RAN- TES[J].J Am Scc Nephrol,2004, 15,2868 -2881.
  • 9ANTUSB ,EXTONMS. AngioLension Ⅱ :a regulator of inflammaLion during renal disease[ J]. Int J Immunopathol Phannacol, 2001, 14( 1 ) :2.5 -30.
  • 10Marta RO, Carmen B, Moguel A, et al. Angiotension Ⅱ participates in mono - nuclear cell recruitment in exper/menta immune complex nephritis through nuclear factor - κB activation and monocyte che- moattractant protein - 1 synthesis[J]. J Immunol. 1998,1611( 1 ) : 430 -439.

引证文献4

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部